The new location houses the primary manufacturing operations for the company’s biologic products.
Pioneer Biologics GM Shane Ray said expanding their biomanufacturing facility to increase their capacity will assist in aggressive future growth plans within and outside the US.
Ray’s announcement comes on the heels of the launch of Pioneer’s nanOss Bioactive 3D, the newest addition to its bone graft product line, nanOss Bioactive.
Pioneer Surgical Biologics now provides a full line of synthetic bone grafts, human tissue products including machined lateral, traditional lumbar and cervical allograft, human demineralized bone matrix (DBM) bone grafts, as well as bone graft delivery accessories.
